Postchemoradiotherapy Neutrophil-to-Lymphocyte Ratio Predicts Distant Metastasis and Survival Results in Locally Advanced Pancreatic Cancers

<div>Receiver operating characteristic curve analysis results examining the relationship between the posttreatment neutrophil-to-lymphocyte ratio and survival outcomes. (a) Overall survival and (b) distant metastasis-free survival.</div>

International Journal of Clinical Practice

fig1

Figure 1

Figure 1: Postchemoradiotherapy Neutrophil-to-Lymphocyte Ratio Predicts Distant Metastasis and Survival Results in Locally Advanced Pancreatic Cancers 

Figure 1 | Postchemoradiotherapy Neutrophil-to-Lymphocyte Ratio Predicts Distant Metastasis and Survival Results in Locally Advanced Pancreatic Cancers 